Seidenberg Jürgen
Universitätsklinik für Kinder- und Jugendmedizin, Klinik für Pädiatrische Pneumologie und Allergologie, Klinikum Oldenburg AöR, Rahel-Straus-Straße 10, 26133, Oldenburg, Deutschland.
Internist (Berl). 2019 Nov;60(11):1146-1150. doi: 10.1007/s00108-019-00673-3.
Respiratory syncytial virus (RSV) is worldwide a very important virus leading to infection of the respiratory system. In particular preterm babies, infants and elderly adults are prone to developing severe diseases such as bronchiolitis or pneumonia, which require intensive care and cause increased mortality. Although RSV is rapidly detected, preventive and therapeutic measures are limited. New antivirals are already in clinical trials.
呼吸道合胞病毒（RSV）在全球范围内是一种导致呼吸系统感染的非常重要的病毒。特别是早产儿、婴儿和老年人容易患上严重疾病，如细支气管炎或肺炎，这些疾病需要重症监护并会导致死亡率上升。尽管RSV能被快速检测出来，但预防和治疗措施却很有限。新型抗病毒药物已在进行临床试验。
